115 related articles for article (PubMed ID: 1157188)
1. Structure and activity relationships of platinum complexes with anti-tumour activity.
Braddock PD; Connors TA; Jones M; Khokhar AR; Melzack DH; Tobe ML
Chem Biol Interact; 1975 Sep; 11(3):145-61. PubMed ID: 1157188
[TBL] [Abstract][Full Text] [Related]
2. Analogues of cisplatin derived from diaminodideoxytetritols. Synthesis and activity against the ADJ/PC6 plasmacytoma in mice.
Haines AH; Morley C; Murrer BA
J Med Chem; 1989 Apr; 32(4):742-5. PubMed ID: 2704024
[TBL] [Abstract][Full Text] [Related]
3. New platinum complexes with anti-tumour activity.
Connors TA; Jones M; Ross WC; Braddock PD; Khokhar AR; Tobe ML
Chem Biol Interact; 1972 Nov; 5(6):415-24. PubMed ID: 4652593
[No Abstract] [Full Text] [Related]
4. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of the antitumor platinum coordination complexes.
Connors TA; Cleare MJ; Harrap KR
Cancer Treat Rep; 1979; 63(9-10):1499-502. PubMed ID: 498149
[No Abstract] [Full Text] [Related]
6. [Antitumor activity of mixed cis-complexes of platinum(II) with ammonia and cycloalkylamines].
Konovalova AL; Presnov MA; Chel'tsov PA; Kravchenko AN; Ivanov VB
Dokl Akad Nauk SSSR; 1985; 281(1):200-3. PubMed ID: 4039648
[No Abstract] [Full Text] [Related]
7. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of therapeutic doses of isotopically labeled platinum antitumor agents in the mouse and rat.
Robins AB; Leach MO
Cancer Treat Rep; 1983 Mar; 67(3):245-52. PubMed ID: 6682013
[TBL] [Abstract][Full Text] [Related]
9. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
[TBL] [Abstract][Full Text] [Related]
10. Platinum complexes of substituted ethylenediamines and their anti-tumour activity.
Beaumont KP; McAuliffe CA; Cleare MJ
Chem Biol Interact; 1976 Jul; 14(1-2):179-93. PubMed ID: 954137
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.
Raynaud FI; Boxall FE; Goddard P; Barnard CF; Murrer BA; Kelland LR
Anticancer Res; 1996; 16(4A):1857-62. PubMed ID: 8712713
[TBL] [Abstract][Full Text] [Related]
12. Structure-antitumour activity relationships for new platinum complexes.
Craciunescu DG; Doadrio A; Furlani A; Scarcia V
Chem Biol Interact; 1982 Nov; 42(2):153-64. PubMed ID: 6891293
[TBL] [Abstract][Full Text] [Related]
13. Coordination complexes of platinum as antitumor agents.
Speer RJ; Ridgway H; Hall LM; Stewart DP; Howe KE; Lieberman DZ; Newman AD; Hill JM
Cancer Chemother Rep; 1975; 59(3):629-41. PubMed ID: 1203887
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of water-soluble platinum(II) complexes of 1,2-cyclohexanediamine isomers.
Kidani Y; Noji M; Tsukagoshi S; Tashiro T
Gan; 1978 Apr; 69(2):263-5. PubMed ID: 680465
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.
Kidani Y; Inagaki K; Iigo M; Hoshi A; Kuretani K
J Med Chem; 1978 Dec; 21(12):1315-8. PubMed ID: 722741
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
19. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
